TABLE 2.

Dog identification number, gender, age, and type of B. subtilis spore orally applied

Animal no.	Gendere	Age (wk)a	B. subtilis spores appliedb
1, 2	M, M	2	tasA sinR lux TasA-mCherry
3	F	9	Placeboc
4, 5	M, F	9	tasA sinR lux TasA-mCherry
1, 2	F, M	9	Placebo
1, 2	M, F	9	tasA sinR TasA-(102-207)EgTrp
1, 2	M, F	9	tasA sinR TasA-(370-583)EgA31
1, 2	M, F	9	Mixtured

^aThe age at the time that the first B. subtilis spores were received.

^bA total of 5 × 10¹⁰ CFU of orally applied recombinant B. subtilis spores per dose.

^cThe placebo consisted of milk.

^dA total of 2.5 × 10¹⁰ CFU B. subtilis tasA sinR TasA-(102-207)EgTrp and 2.5 ×10¹⁰ CFU B. subtilis tasA sinR TasA-(370-83)EgA31 spores per dose.

^eF, female; M, male.